The EVP & CFO of Quest Diagnostics Inc is Exercising Options


Yesterday it was reported that the EVP & CFO of Quest Diagnostics Inc (DGX), Mark Guinan, exercised options to sell 73,005 DGX shares at $52.16 a share, for a total transaction value of $7.3M.

Following Mark Guinan’s last DGX Sell transaction on May 07, 2014, the stock climbed by 51.5%. In addition to Mark Guinan, one other DGX executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Quest Diagnostics Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $1.89 billion and quarterly net profit of $163 million. In comparison, last year the company earned revenue of $1.88 billion and had a net profit of $176 million. DGX’s market cap is $13.54B and the company has a P/E ratio of 19.51. Currently, Quest Diagnostics Inc has an average volume of 895.8K.

Based on 8 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $103.25, reflecting a 1.3% upside.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts